par Dinh, Phuong ;Azambuja, Evandro ;Cardoso, Fatima ;Piccart-Gebhart, Martine
Référence Nature clinical practice. Oncology, 5, 11, page (645-654)
Publication Publié, 2008-11
Article révisé par les pairs
Titre:
  • Facts and controversies in the use of trastuzumab in the adjuvant setting.
Auteur:Dinh, Phuong; Azambuja, Evandro; Cardoso, Fatima; Piccart-Gebhart, Martine
Informations sur la publication:Nature clinical practice. Oncology, 5, 11, page (645-654)
Statut de publication:Publié, 2008-11
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antibodies, Monoclonal -- therapeutic use
Antineoplastic Agents -- therapeutic use
Belgium
Breast Neoplasms -- drug therapy
Breast Neoplasms -- economics
Breast Neoplasms -- genetics
Breast Neoplasms -- mortality
Chemotherapy, Adjuvant
Clinical Trials as Topic
Cost-Benefit Analysis
Female
Humans
Neoplasm Recurrence, Local -- economics
Neoplasm Recurrence, Local -- prevention & control
Phenotype
Receptor, erbB-2 -- genetics
Risk Assessment
Survival Analysis
Treatment Outcome
Tumor Markers, Biological -- genetics
Note générale:Journal Article
Review
Langue:Anglais
Identificateurs:urn:issn:1743-4262
info:doi/10.1038/ncponc1219
info:pii/ncponc1219
info:scp/55549120522
info:pmid/18779850